The Company's MAA to MHRA in the U.K. is in the active process of responses to questions received from MHRA. Nymox will update later in the cycle when appropriate
NWBO could do this but chooses not to. Single product OTC biotechs with no money only do this to bury bad news.
Market Data 
Markets 
AI
